US FDA approves DermaSensor device to detect skin cancer with AI
Privately held device maker DermaSensor said Wednesday that the U.S. Food and Drug Administration has cleared its handheld device that uses artificial intelligence to detect skin cancer.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM